Tumor-infiltrating lymphocyte as a prognostic biomarker in stage IV colorectal cancer should take into account the metastatic status and operation modality

被引:19
|
作者
Xie, Qian-Kun [1 ]
He, Wen-Zhuo [1 ]
Hu, Wan-Ming [2 ,3 ,4 ]
Yang, Lin [1 ]
Jiang, Chang [1 ]
Kong, Peng-Fei [1 ]
Yang, Yuan-Zhong [2 ]
Yang, Qiong [1 ,5 ]
Zhang, Hui-Zhong [2 ]
Zhang, Bei [1 ]
Xia, Liang-Ping [1 ]
机构
[1] Sun Yat Sen Univ, Canc Ctr, Collaborat Innovat Ctr Canc Med, VIP Reg State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Canc Ctr, Collaborat Innovat Ctr Canc Med, Dept Pathol,State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China
[3] Southern Med Univ, Sch Basic Med Sci, Dept Pathol, Guangzhou, Guangdong, Peoples R China
[4] Southern Med Univ, Dept Pathol, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China
[5] Sun Yat Sen Mem Hosp, Dept Oncol, Guangzhou, Guangdong, Peoples R China
来源
CANCER MANAGEMENT AND RESEARCH | 2018年 / 10卷
基金
中国国家自然科学基金;
关键词
colorectal cancer; stage IV; tumor-infiltrating lymphocytes; metastatic status; survival; MOLECULAR-BASIS; BREAST-CANCER; PATTERN;
D O I
10.2147/CMAR.S162147
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Although tumor-infiltrating lymphocytes (TILs) have been understood for years as a favorable prognostic factor for colorectal cancers (CRCs) after complete surgical resection, its prognostic role in metastatic CRC (mCRC) remains poorly defined, and it is largely unknown how this prognostic benefit relates to the metastatic status and operation modality. Materials and methods: After reviewing 2215 consecutive cases of surgically resected CRC, 332 patients newly diagnosed with stage IV CRC and treated at the Sun Yat-Sen University Cancer Center between 2009 and 2014 were included. H&E-stained (HES) slides from surgical specimens were evaluated for the extent of TILs. The primary end point was overall survival (OS). Cox proportional hazards regression was conducted to determine the prognostic significance of TILs. All statistical tests were 2-sided. Results: HES slides from primary tumor samples were evaluable for 302 of the 332 included cases. Among the 302 patients, 105 patients (34.8%) were classified as high TIL, the remaining 197 (65.2%) were defined as low TIL. In the univariate analysis, TILs were significantly associated with better OS (P=0.015). Multivariable analysis confirmed that high TIL strongly predicted better survival (hazard ratio =0.62, 95% CI: 0.44-0.89, P=0.008), independent of other patients' clinicopathological characteristics. Stratified analysis revealed a prognostic benefit of high TIL for patients in the subgroup with non-oligometastatic disease (P=0.002), >= 2 metastatic organs (P=0.006), and non-metastasectomy (P=0.005). By contrast, oligometastatic disease, 1 metastatic organ, or metastasectomy fully abrogated the prognostic effect of TIL. Conclusion: Our findings indicate that the level of TILs can be used to predict the outcome for patients with mCRC; however, the operation modality and the metastatic status of patients should also be taken into account.
引用
收藏
页码:1365 / 1375
页数:11
相关论文
共 50 条
  • [41] Artificial intelligence-based analysis of tumor-infiltrating lymphocyte spatial distribution for colorectal cancer prognosis
    Cai Ming
    Zhao Ke
    Wu Lin
    Huang Yanqi
    Zhao Minning
    Hu Qingru
    Chen Qicong
    Yao Su
    Li Zhenhui
    Fan Xinjuan
    Liu Zaiyi
    中华医学杂志英文版, 2024, 137 (04)
  • [42] Tumor-infiltrating Immune Cells in H&E-stained Sections of Colorectal Cancer Tissue as a Reasonable Immunological Biomarker
    Matsutani, Shinji
    Shibutani, Masatsune
    Maeda, Kiyoshi
    Nagahara, Hisashi
    Fukuoka, Tatsunari
    Iseki, Yasuhito
    Kashiwagi, Shinichiro
    Tanaka, Hiroaki
    Hirakawa, Kosei
    Ohira, Masaichi
    ANTICANCER RESEARCH, 2018, 38 (12) : 6721 - 6727
  • [43] The Impact of Nutritional Status and Tumor-Infiltrating Lymphocytes (CD4+and CD8+) on Chemotherapy Response in Colorectal Cancer Patients
    Lukman, Kiki
    Septianto, Rhandy
    Rudiman, Reno
    Ruchimat, Tommy
    Sribudiani, Yunia
    Nugraha, Prapanca
    Primastari, Etis
    Budiman, Deny
    CANCER MANAGEMENT AND RESEARCH, 2025, 17 : 197 - 209
  • [44] Development of a Prognostic Model for Stage IV Colorectal Cancer Using Metastatic Patterns
    Kawamura, Hidetaka
    Imaizumi, Takahiro
    Miyakawa, Teppei
    Nakao, Eiichi
    Katagata, Masanori
    Todate, Yukitoshi
    Takano, Yoshinao
    Kono, Koji
    Honda, Michitaka
    ANTICANCER RESEARCH, 2025, 45 (01) : 341 - 350
  • [45] SPP1 is a prognostic related biomarker and correlated with tumor-infiltrating immune cells in ovarian cancer
    Gao, Wen
    Liu, Dongli
    Sun, Haiyan
    Shao, Zhuyan
    Shi, Peipei
    Li, Tingting
    Yin, Sheng
    Zhu, Tao
    BMC CANCER, 2022, 22 (01)
  • [46] Tumor-infiltrating lymphocyte quantification stratifies early-stage human papillomavirus oropharynx cancer prognosis
    Faraji, Farhoud
    Fung, Nicholas
    Zaidi, Munfarid
    Gourin, Christine C.
    Eisele, David W.
    Rooper, Lisa M.
    Fakhry, Carole
    LARYNGOSCOPE, 2020, 130 (04) : 930 - 938
  • [47] The Prognostic Value of Tumor-Infiltrating lymphocytes in Stage II Colon Cancer. A Nationwide Population-Based Study
    Eriksen, Ann C.
    Sorensen, Flemming B.
    Lindebjerg, Jan
    Hager, Henrik
    Christensen, Rene dePont
    Kjaer-Frifeldt, Sanne
    Hansen, Torben F.
    TRANSLATIONAL ONCOLOGY, 2018, 11 (04): : 979 - 987
  • [48] Significance of Siglec-15 expression in colorectal cancer: association with advanced disease stage and fewer tumor-infiltrating lymphocytes
    Lu, Zhao
    Cheng, Pu
    Huang, Fei
    Li, Jiyun
    Wang, Bingzhi
    Zou, Shuangmei
    Zheng, Zhaoxu
    Peng, Chunwei
    JOURNAL OF PATHOLOGY CLINICAL RESEARCH, 2023, 9 (02) : 121 - 128
  • [49] Evaluation of cell surface vimentin positive circulating tumor cells as a prognostic biomarker for stage III/IV colorectal cancer
    Cao, Yuepeng
    Yang, Mian
    Peng, Tao
    Liu, Yelei
    Yu, Jiazi
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [50] Prognostic value of tumor infiltrating lymphocyte subsets in breast cancer depends on hormone receptor status
    Yul Ri Chung
    Hyun Jeong Kim
    Min Hye Jang
    So Yeon Park
    Breast Cancer Research and Treatment, 2017, 161 : 409 - 420